Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour doppler ultrasonography: A preliminary study

Brain and Language

Volumn 52, Issue 1, 1997, Pages 41-45

  Tano, S ^a   Ueno, N ^a   Tomiyama, T ^a   Kimura, K ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; SHU 508;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DOPPLER ECHOGRAPHY; FATTY LIVER; FEMALE; HEART CONTRACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER TUMOR; MALE; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 23744475203     PISSN: 0093934X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0009-9260(97)80304-2     Document Type: Article

References (19)

1. Tanaka S, Kitamura T, Fujita M et al. Color Doppler flow imaging of liver tumours. American Journal of Radiology 1990;154:509-514.
2. Lencioni R, Caramella D, Bartolozzi C. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology 1995; 194: 113-118.
3. Golli M, Nhieu JT, Mathieu D et al. Hepatocellular adenoma: color Doppler US and pathologic correlations. Radiology 1994;190:741-744.
4. Yoshikawa J, Matsui O, Takashima T et al. Fatty metamorphosis in hepatocellular carcinoma: radiologic features in 10 cases. American Journal of Radiology 1988;151:717-720.
5. Smith MD, Elion JL, McClure RR et al. Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs. Journal of the American College of Cardiologists 1989;13:1622-1628.
6. Goldberg BB, Hilpert PL, Burns PN et al. Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent. Radiology 1990;177:713-717.
7. Goldberg BB, Liu J, Burns PN. Galactose-based intravenous sonographic contrast agent: experimental studies. Journal of Ultrasound Mecicine 1993;12:463-470.
8. Fritzsch T, Hilmann J, Kampfe M et al. SH U 508, a transpulmonary echocontrast agent. Initial experience. Investigative Radiology 1990;25:S160-S161.
9. Maresca G, Barbaro B, Summaria V et al. Color Doppler ultrasonography in the differential diagnosis of focal hepatic lesions. The SH U 508 A (Levovist) experience. Radiology Medicine, Torino 1994;87:41-49.
10. Angeli E, Carpanelli R, Crespi G et al. Efficacy of SHU U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization. Radiology Medicine Torino 1994;87:24-31.
11. Tanaka S, Kitamura T, Yoshioka F et al. Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma. Ultrasound in Medicine & Biology 1995;21:157-160.
12. Ohto M, Matsutani S, Mizumoto H et al. Evaluation of color Doppler using a saccharide-based contrast agent, SH/TA-508, on liver tumors: a phase II clinical study. Japanese Journal of Medical Ultrasonics 1995;22:461 (abstract).
13. Yoshimatsu S, Inoue Y, Ibukuro K et al. Hypovascular hepatocellular carcinoma undetected at angiography and CT with iodized oil. Radiology 1989;171:343-347.
14. Sonoda T, Shirabe K, Takenaka K et al. Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment. Hepatology 1989;10: 1003-1007.
15. 2 microbubbles. Radiology 1986;161:701-705.
16. 2 micro-bubbles. Radiology 1992;182:155-160.
17. Nilsson LAV, Zettergren L. Effect of hepatic artery ligation on induced primary liver carcinoma in rats: preliminary report. Acta Pathologica Microbiolica Scandinavica 1976;71:187-193.
18. Ackerman NB. The blood supply of experimental liver metastasis: changes in vascularity with increasing tumor growth. Surgery 1974;75:589-596.
19. Balen FG, Allen CM, Lees WR. Review: ultrasound contrast agent. Clinical Radiology 1994;49:77-82.